Home Cart 0 Sign in  

[ CAS No. 1937-19-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1937-19-5
Chemical Structure| 1937-19-5
Structure of 1937-19-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1937-19-5 ]

Related Doc. of [ 1937-19-5 ]

Alternatived Products of [ 1937-19-5 ]

Product Details of [ 1937-19-5 ]

CAS No. :1937-19-5 MDL No. :MFCD00039074
Formula : CH7ClN4 Boiling Point : -
Linear Structure Formula :- InChI Key :UBDZFAGVPPMTIT-UHFFFAOYSA-N
M.W : 110.55 Pubchem ID :2734687
Synonyms :
Pimagedine hydrochloride;GER-11;Guanylhydrazine hydrochloride;GER11. aminoguanidine. Pimagedine hydrochloride;MDL201228;YM-585;Pimagedine, MDL-201228;Aminoguanidine (hydrochloride);Monoaminoguanidine;Imino semicarbazide;Hydrazinecarboximidamide;Guanyl hydrazine;Pimagedine;Aminoguanidinium chloride;Aminoguanidine hydrochloride

Calculated chemistry of [ 1937-19-5 ]

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 4.0
Molar Refractivity : 25.69
TPSA : 87.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : -0.89
Log Po/w (WLOGP) : -0.85
Log Po/w (MLOGP) : -1.0
Log Po/w (SILICOS-IT) : -1.01
Consensus Log Po/w : -0.75

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.1
Solubility : 140.0 mg/ml ; 1.26 mol/l
Class : Highly soluble
Log S (Ali) : -0.47
Solubility : 37.1 mg/ml ; 0.336 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.83
Solubility : 742.0 mg/ml ; 6.71 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.68

Safety of [ 1937-19-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1937-19-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1937-19-5 ]
  • Downstream synthetic route of [ 1937-19-5 ]

[ 1937-19-5 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 131543-46-9 ]
  • [ 1937-19-5 ]
  • [ 1120-99-6 ]
Reference: [1] ChemMedChem, 2016, p. 1778 - 1789
  • 2
  • [ 2582-30-1 ]
  • [ 1937-19-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 26, p. 7897 - 7901
[2] Russian Journal of Applied Chemistry, 2008, vol. 81, # 10, p. 1813 - 1817
[3] Journal of Medicinal Chemistry, 2008, vol. 51, # 24, p. 8168 - 8172
[4] Organic and Biomolecular Chemistry, 2010, vol. 8, # 4, p. 873 - 880
[5] Chemistry - A European Journal, 2017, vol. 23, # 46, p. 11159 - 11168
  • 3
  • [ 1309884-92-1 ]
  • [ 1937-19-5 ]
  • [ 64-19-7 ]
Reference: [1] Russian Journal of Applied Chemistry, 2011, vol. 84, # 3, p. 400 - 406
  • 4
  • [ 102-52-3 ]
  • [ 1937-19-5 ]
  • [ 4023-02-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 24, p. 8168 - 8172
  • 5
  • [ 878671-95-5 ]
  • [ 1937-19-5 ]
  • [ 878671-96-6 ]
YieldReaction ConditionsOperation in experiment
76% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; for 12 h; The intermediate compound V (13.3mmol, 3.0g), aminoguanidine hydrochloride (26.6mmol, 2.9g) was added to 50mL of N, N-dimethyl formamide, was added under stirring N, N-diisopropylethylamine amine (39.9mmol, 5.1g), then the reaction 50 12h, the solvent was evaporated to dryness 20mL2M sodium hydroxide was added, and the reaction was continued 50 12h. After stopping the reaction, the reaction mixture was filtered, and the filtrate was washed with dilute hydrochloric acid to pH = 4, shows a large number of white precipitate was filtered, and then at a temperature of 45-50 dried under vacuum to give 2.85g the VI intermediate compound,(76percent)
49%
Stage #1: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; for 15 h;
Stage #2: With sodium hydroxide In water at 50℃; for 60 h;
A mixture of aminoguanidine hydrochloride (3.18 g, 29 mmol), l-cyclopropyl-4- isothiocyanato-naphthalene (3.24 g, 14 mmol) and diisopropylethylamine (3 eq) in DMF (20 mL) was stirred at 50 0C for 15 hours. The solvent was evaporated, toluene was added, and the solvent was evaporated again. A 2.0 M aqueous solution of sodium hydroxide (30 mL) was added and the reaction mixture was heated at 50 0C for 60 hours. The reaction mixture was filtered, and the filtrate was neutralized with a 2.0 M aqueous solution of HCl. New filtration, then evaporation of solvent and purification of the residue by silica gel chromatography to yield 5-amino-4-(4-cyclopropylnaphthalen-l-yl)- 4H-[l,2,4]triazole-3-thiol (2.0 g, 49percent).
49%
Stage #1: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; for 15 h;
Stage #2: at 50℃; for 60 h;
Stage #3: With hydrogenchloride In water
STEP E: 5-Amino-4-(l-cyclopropylnaphthalen-4-yl)-4H-l,2,4-triazole-3- thiolA mixture of aminoguanidine hydrochloride (3.18 g, 29 mmol), l-cyclopropyl-4- isothiocyanato naphthalene (3.24 g, 14 mmol) and diisopropylethylamine (3 eq) in DMF (20 mL) was stirred at 50 °C for 15 hours. The solvent was removed under reduced pressure, toluene added, and the solvent was evaporated again. Sodium hydroxide solution (2M, 30 mL) was added and the reaction mixture heated at 50 °C for 60 hours. The reaction mixture was filtered and the filtrate neutralized with aqueous HCl (2M). The mixture was re-filtered and the solvent removed under reduced pressure. The residue was purified by silica gel chromatography to yield 5-amino-4-(l-cyclopropylnaphthalen-4-yl)-4H-l,2,4-triazole-3- thiol (2.0 g, 49percent).
Reference: [1] Patent: CN105566237, 2016, A, . Location in patent: Paragraph 0066; 0067; 0068
[2] Patent: WO2009/70740, 2009, A2, . Location in patent: Page/Page column 89-90
[3] Patent: WO2006/26356, 2006, A2, . Location in patent: Page/Page column 21
[4] Patent: WO2011/85009, 2011, A2, . Location in patent: Page/Page column 37
Same Skeleton Products
Historical Records